Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
32,270,909
-
Total 13F shares
-
2,332,205
-
Share change
-
-474,330
-
Total reported value
-
$3,240,559
-
Price per share
-
$1.39
-
Number of holders
-
31
-
Value change
-
-$616,944
-
Number of buys
-
13
-
Number of sells
-
30
Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q3 2025
As of 30 Sep 2025 Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,332,205 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES FINANCIAL INC, UBS Group AG, STATE STREET CORP, Bank of New York Mellon Corp, Suncoast Equity Management, and NORTHERN TRUST CORP.
This table shows 31 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.